Personalized therapy for mycophenolate: consensus report by the international association of therapeutic drug monitoring and clinical toxicology

S Bergan, M Brunet, DA Hesselink… - Therapeutic drug …, 2021 - journals.lww.com
When mycophenolic acid (MPA) was originally marketed for immunosuppressive therapy,
fixed doses were recommended by the manufacturer. Awareness of the potential for a more …

Renal drug transporters and drug interactions

A Ivanyuk, F Livio, J Biollaz, T Buclin - Clinical pharmacokinetics, 2017 - Springer
Transporters in proximal renal tubules contribute to the disposition of numerous drugs.
Furthermore, the molecular mechanisms of tubular secretion have been progressively …

The role of uptake and efflux transporters in the disposition of glucuronide and sulfate conjugates

E Järvinen, F Deng, W Kiander, A Sinokki… - Frontiers in …, 2022 - frontiersin.org
Glucuronidation and sulfation are the most typical phase II metabolic reactions of drugs. The
resulting glucuronide and sulfate conjugates are generally considered inactive and safe …

Glucuronidation: driving factors and their impact on glucuronide disposition

G Yang, S Ge, R Singh, S Basu, K Shatzer… - Drug metabolism …, 2017 - Taylor & Francis
Glucuronidation is a well-recognized phase II metabolic pathway for a variety of chemicals
including drugs and endogenous substances. Although it is usually the secondary metabolic …

Three dimensional modeling of biologically relevant fluid shear stress in human renal tubule cells mimics in vivo transcriptional profiles

EJ Ross, ER Gordon, H Sothers, R Darji, O Baron… - Scientific Reports, 2021 - nature.com
The kidney proximal tubule is the primary site for solute reabsorption, secretion and where
kidney diseases can originate, including drug-induced toxicity. Two-dimensional cell culture …

[HTML][HTML] How cyclosporine reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do not

T van Gelder - Kidney International, 2021 - Elsevier
The most frequently used immunosuppressive treatment in kidney transplant recipients is
the combination therapy of a calcineurin inhibitor and mycophenolate mofetil (MMF), with or …

The pharmacological and physiological role of multidrug-resistant protein 4

J Wen, J Luo, W Huang, J Tang, H Zhou… - Journal of Pharmacology …, 2015 - ASPET
Multidrug-resistant protein 4 (MRP4), a member of the C subfamily of ATP-binding cassette
transporters, is distributed in a variety of tissues and a number of cancers. As a drug …

ABCG2/BCRP: variants, transporter interaction profile of substrates and inhibitors

Z Safar, E Kis, F Erdo, JK Zolnerciks… - Expert Opinion on Drug …, 2019 - Taylor & Francis
Introduction: ABCG2 has a broad substrate specificity and is one of the most important efflux
proteins modulating pharmacokinetics of drugs, nutrients and toxicokinetics of toxicants …

[HTML][HTML] Abcc6 knockout rat model highlights the role of liver in PPi homeostasis in pseudoxanthoma elasticum

Q Li, J Kingman, K van de Wetering, S Tannouri… - Journal of Investigative …, 2017 - Elsevier
Pseudoxanthoma elasticum, a heritable ectopic mineralization disorder, is caused by
mutations in the ABCC6 gene primarily expressed in the liver and the kidneys. The …

Effects of ischemia-reperfusion on tubular cell membrane transporters and consequences in kidney transplantation

Q Faucher, H Alarcan, P Marquet… - Journal of Clinical …, 2020 - mdpi.com
Ischemia-reperfusion (IR)-induced acute kidney injury (IRI) is an inevitable event in kidney
transplantation. It is a complex pathophysiological process associated with numerous …